In Vivo
Delivery
Our in vivo delivery offers a simpler alternative to complex ex vivo gene therapies. Instead of modifying cells outside the body, we deliver gene-editing tools directly to cells within the patient. This in vivo approach avoids the challenges and limitations of traditional cell-based manufacturing and transplantation.
Pipeline
Protein Delivery Vehicles (PDVs) delivered in vivo CRISPR therapy
Stromal corneal dystrophy
Undisclosed
Undisclosed
Lipid nanoparticles (LNPs) delivered in vivo CRISPR therapy
Rare disease
Undisclosed
Metabolic disease
Undisclosed
|
Program |
Discovery |
Preclinical |
IND-enabling |
Clinical |
Approval |
Available for out-licensing
Available for out-licensing
Copyright © 2025 GenEditBio
Provide affordable precision DNA surgery for genetic diseases with unmet needs
Business Contact bd@geneditbio.com
Media Contact geb.media@geneditbio.com
HONG KONG Unit 101-102, Building 6W, 6 Science Park West Avenue, Hong Kong hkoffice@geneditbio.com
BEIJING 4/F, Building 29, Yard 18, Kechuang 13th St, VPark, Beijing
